Company

Beckman Coulter Genomics, headquartered in Danvers, Massachusetts, sets the standard for delivering expert genomics solutions to life science and healthcare businesses as well as academic and government institutions worldwide. By providing technical expertise, combined with personalized service, Beckman Coulter Genomics delivers the highest quality data, robust analyses and innovative thinking.

From classic to cutting-edge, Beckman Coulter Genomics has expertise and experience on a wide range of genomic technology platforms and is dedicated to delivering the highest quality results. Services currently available include next generation and Sanger sequencing, sample preparation, and biologics testing, with support for all levels of regulatory compliance, including Clinical Laboratory Improvement Amendments (CLIA). In addition, Beckman Coulter Genomics offers the best next generation sequencing platforms: Roche* 454 Genome Sequencer FLX+, Illumina* HiSeq 2000 and Illumina GAIIx.

“We understand that each customer, each sample and each study is unique and extremely important. That is why we strive to create a partnership with each customer through a consistent and personalized approach. Our experienced team has the energy and resolve needed to deliver high-quality results scientists can trust.”